Skip to main content
Clinical Trials/NCT01390168
NCT01390168
Completed
N/A

Tailored Internet-administrated Treatment of Anxiety Disorders - A Randomised Controlled Trial (NOVA II)

Umeå University1 site in 1 country100 target enrollmentJanuary 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Anxiety Disorders
Sponsor
Umeå University
Enrollment
100
Locations
1
Primary Endpoint
Change from baseline in Clinical Outcome in Routine Evaluation - Outcome Measure (CORE-OM)
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to determine whether tailored internet-administered cbt is a feasible treatment for anxiety disorders in clinical settings.

Registry
clinicaltrials.gov
Start Date
January 2010
End Date
December 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Per Carlbring, PhD

Professor

Umeå University

Eligibility Criteria

Inclusion Criteria

  • over 18 years
  • fulfill the criteria for at least one anxiety syndrome

Exclusion Criteria

  • ongoing psychological treatment
  • suicidal prone
  • ongoing alcohol addiction

Outcomes

Primary Outcomes

Change from baseline in Clinical Outcome in Routine Evaluation - Outcome Measure (CORE-OM)

Time Frame: Two weeks pre treatment (baseline), two weeks post treatment, and 12 months post treatment

Measures anxiety and depressive symptoms. Change from baseline in anxiety and depressive symptoms expected between time frames.

Secondary Outcomes

  • Change from baseline in Beck Anxiety Inventory (BAI)(Two weeks pre treatment (baseline), two weeks post treatment, 12 months post treatment)
  • Change from baseline in Montgomery Åsberg Depression Rating Scale-Self Rated (MADRS-S)(Two weeks pre treatment (baseline), two weeks post treatment, and 12 months post treatment)
  • Change from baseline in Quality of Life Inventory (QOLI)(Two weeks pre treatment (baseline), two weeks post treatment, and 12 months post treatment)

Study Sites (1)

Loading locations...

Similar Trials